The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
Regular check-ins with your healthcare provider can help assess your progress and make necessary adjustments to your treatment plan
And we now have wonderful electron microscopy of red blood cells in the alveolar space itself, Dr
For oral semaglutide (Rybelsus), the FDA prescribing information specifically notes increased thyroxine exposure when co-administered with levothyroxine, requiring thyroid parameter monitoring
Strength training 23 times per week helps maintain muscle during calorie deficits
However, semaglutide has also been shown to be effective at promoting weight loss